8,517 articles
Jean‐Christophe Leroux
Jean-Christophe Leroux (born 1969 in Montreal) is a drug formulation and delivery scientist, full professor and institute head at ETH Zurich, known for biodetoxification and co-founding the spin-offs Versantis AG and Inositec AG.
Jean‐Claude Tardif
Jean-Claude Tardif is a Canadian cardiologist and professor at the Université de Montréal who directs the Montreal Heart Institute Research Centre and led the COLCOT colchicine trial.
Jean‐François Bach
Jean-François Bach (1940–2023) was a French immunologist at Hôpital Necker in Paris who isolated thymulin, pioneered immunotherapy for type 1 diabetes, and championed the hygiene hypothesis.
Jean‐Frédéric Colombel
Jean-Frédéric Colombel is a French gastroenterologist specializing in inflammatory bowel disease who directs the Feinstein IBD Clinical Center at the Icahn School of Medicine at Mount Sinai.
Jean‐Louis Mas
Jean-Louis Mas is a French neurologist and stroke researcher who headed neurology at Hôpital Sainte-Anne in Paris from 1995 to 2022, known for the CLOSE and EVA-3S trials.
Jean‐Louis Vincent
Jean-Louis Vincent is a Belgian professor of intensive care medicine at the Université libre de Bruxelles and Erasme Hospital, co-creator of the SOFA score used in defining sepsis.
Jean‐Marie Andrieu
Jean-Marie Andrieu was a French hematologist, oncologist, and professor of medicine at Université Paris Descartes who led Hôpital Européen Georges Pompidou's oncology department and developed therapeutic dendritic-cell vaccines against HIV.
Jean‐Michel Dayer
Jean-Michel Dayer (born 1942) is a Swiss physician-scientist in immunology and rheumatology at the University of Geneva, known for identifying factors driving joint destruction in rheumatoid arthritis.
Jean‐Michel Molina
Jean-Michel Molina is a French infectious-diseases physician-researcher, professor at Université Paris Cité and head of infectious diseases at Hôpital Saint-Louis, known for leading the IPERGAY on-demand PrEP trial and the lenacapavir CAPELLA trial.
Jean‐Pierre Benhamou
Jean-Pierre Benhamou (1927–2008) was a French hepatologist who led the liver unit at Hôpital Beaujon in Clichy, directed an INSERM liver research unit, and is remembered as the father of modern hepatology in Europe.
Jean‐Pierre Cartron
Jean-Pierre Cartron is a French biochemist and physician-scientist at the Institut national de transfusion sanguine in Paris, known for defining the molecular basis of human blood group systems.
Jean‐Pierre Després
Jean-Pierre Després is a Canadian kinesiologist and exercise physiologist at Université Laval whose research on visceral obesity and insulin resistance made waist measurement routine medical practice worldwide.
Jean‐Yves Blay
Jean-Yves Blay is a French medical oncologist, Directeur général of the Centre Léon Bérard in Lyon, professor at Université Claude Bernard Lyon 1, and president of Unicancer.
Jean‐Yves Delattre
Jean-Yves Delattre is a French neurologist and neuro-oncologist who leads neuro-oncology at the Pitié-Salpêtrière hospital in Paris, and led the 2007 trial establishing radiotherapy for elderly glioblastoma patients.
Jean‐Yves Douillard
Jean-Yves Douillard is a French medical oncologist who worked on lung and gastrointestinal cancers, led the PRIME trial of panitumumab, and became ESMO's first Chief Medical Officer in 2016.
Jean–Michel Pawlotsky
Jean-Michel Pawlotsky, born in 1961, is a French physician-scientist in hepatology and virology, professor at Université Paris-Est Créteil and director of virology at Hôpital Henri Mondor in Créteil.
Jeane Ann Grisso
Jeane Ann Grisso is an American physician and epidemiologist at the University of Pennsylvania known for case-control studies of falls, hip fracture, and violent injury in women.
Jeanmarie Houghton
Jeanmarie Houghton is an American physician-scientist and Professor of Medicine at UMass Chan Medical School, best known for her 2004 Science paper reporting gastric cancer originating from bone marrow-derived cells.
Jeanne Marrazzo
Jeanne Marrazzo is an American infectious diseases physician-scientist who served as NIAID director from 2023 until her removal in 2025, and became CEO of the Infectious Diseases Society of America in 2026.
Jeanne Miranda
Jeanne Miranda is an American clinical psychologist and mental health services researcher, Distinguished University Professor at Florida International University, who studies depression care for low-income and minority populations.
Jeanne S. Mandelblatt
Jeanne S. Mandelblatt is an American geriatrician and professor of oncology at Georgetown University, founder of its Institute for Cancer and Aging Research and leader of CISNET breast cancer modeling.
Jeanne Sinkford
Jeanne Sinkford was an American dentist and educator who in 1975 became the first woman dean of a U.S. dental school, leading Howard University until 1991.
Jedd D. Wolchok
Jedd D. Wolchok is an American physician-scientist in cancer immunotherapy who directs the Meyer Cancer Center at Weill Cornell Medicine and helped develop checkpoint inhibitor drugs for melanoma.
Jędrzej Śniadecki
Jędrzej Śniadecki (1768–1838) was a Polish chemist, physician, and biologist, professor of chemistry at Vilnius, who wrote the first Polish chemistry textbook and coined Polish chemical terms still in use.
Jeff W.M. Bulte
Jeff W.M. Bulte is a Johns Hopkins professor and molecular imaging researcher who pioneered labeling cells with iron oxide nanoparticles so they can be tracked by MRI.
Jeffery M. Stadel
Jeffery M. Stadel is a clinical pharmacology researcher who, as a fellow in Robert Lefkowitz's Duke laboratory, co-authored the 1980 paper proposing the ternary complex model of GPCR activation.
Jeffery M. Vance
Jeffery M. Vance is an American neurogeneticist at the University of Miami known for showing that the APOE-ε4 allele is a major Alzheimer's risk factor.
Jeffrey A. Bluestone
Jeffrey A. Bluestone is an American immunologist and UCSF professor whose research on T-cell tolerance produced CTLA4Ig and teplizumab, the first drug approved to delay type 1 diabetes.
Jeffrey A. Cohen
Jeffrey A. Cohen is an American neurologist specializing in multiple sclerosis at the Cleveland Clinic's Mellen Center, known for leading the 2010 TRANSFORMS trial of oral fingolimod.
Jeffrey A. Engelman
Jeffrey A. Engelman is an American oncologist who studied resistance to targeted kinase inhibitors in lung cancer at Mass General, then joined Novartis in 2016 and co-founded Treeline Biosciences.